Mitochondria Targeting
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
22
NCT04386304
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 13, 2020
Completion: Mar 1, 2022
Loading map...